Article
Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
Redox report : communications in free radical research - 1 Nov 2016
Arpaci Dilek, Karakas Celik Sevim, Can Murat, Ermiş Esra, Kuzu Fatih, Kokturk Furuzan, Hamamcioglu Ayse Ceylan, Dursun Ahmet, Bayraktaroglu Taner
Abstract excerpt
BACKGROUND: Acromegalic patients have increased cardiometabolic risk factors due to an elevation of growth hormone (GH) levels. Human serum paraoxonase (PON), a high-density lipoprotein (HDL)-related enzyme, is one of the major bioscavengers and decreases the oxidation of low-density lipoprotein (LDL), a key regulator in the pathogenesis of atherosclerosis. In this study, we investigated a potential relationship...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
